The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Lessons from rat models of hypertension from Goldblatt to genetic engineering
Abstract
Over the past 50 years various animal models of hypertension have been developed, predominantly in the rat. In this review we discuss the use of the rat as a model of hypertension, and evaluate what these models have taught us. Interestingly, the spontaneously hypertensive rat (SHR) is by far the most widely used rat model, although it reflects only a rare subtype of human hypertension, i.e. primary hypertension that is inherited in a Mendelian fashion. Many other aspects of the etiology of hypertension are found in other rat models, but these models are less frequently employed. The widespread use of the SHR suggests that this rat model is often chosen without considering alternative (and possibly better suited) models. To illustrate the importance of the choice for a particular model, we compared the natural history and response to antihypertensive drugs in different rat models of hypertension (SHR, Dahl, deoxycorticosterone acetate (DOCA)-salt, two-kidney one-clip, transgenic TGR(mRen2)27. This revealed that the outcome of hypertension can be similar in some respects, as all models exhibit cardiac hypertrophy, and all demonstrate impaired endothelium-dependent relaxations. However, the more severe forms of end-organ damage such as heart failure, stroke and kidney failure, occur only in some models and then only in a subset of the hypertensive rats. The effects of antihypertensives varies even more in the different models: antihypertensive treatment only attenuates end-organ damage if it decreases blood pressure. Moreover, if a given antihypertensive is effective, it sometimes even attenuates end-organ damage in nonhypotensive doses. On the other hand, some agents do decrease blood pressure but do not prevent end-organ damage (e.g. hydralazine in SHR). Furthermore, not all classes of antihypertensives are equally effective in all rat models of hypertension: endothelin-receptor antagonists are not effective in SHR, but have beneficial effects in the DOCA-salt model. The comparison of models, and the comparison of treatment effects suggests that end-organ damage critically depends upon not only on the stress imposed by high blood pressure and its underlying biochemical disturbance, but also upon the ability of the organism to recruit adequate 'coping' mechanisms. These coping mechanisms deserve greater attention, as failure to recruit such mechanisms may indicate an increased risk. The current development of transgenic techniques will provide new opportunities, to develop specific models to address this balance between stress and coping.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Development of a Strain of Spontaneously Hypertensive Rats
OKAMOTO, K., & AOKI, K. (1963) · Japanese Circulation Journal · doi:10.1253/jcj.27.282 · Cited by 2,545
STUDIES ON EXPERIMENTAL HYPERTENSION
Goldblatt, H., Lynch, J., Hanzal, R. F., & Summerville, W. W. (1934) · Journal of Experimental Medicine · doi:10.1084/jem.59.3.347 · Cited by 2,142
Hypertension : pathophysiology, diagnosis, and management
Laragh, J. H., & Brenner, B. M. (1995) · Raven Press eBooks · Cited by 1,932
Hypertension: Pathophysiology, Diagnosis, and Management
White, W. B. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03460110128039 · Cited by 944
Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene
Mullins, J. J., Peters, J., & Ganten, D. (1990) · Nature · doi:10.1038/344541a0 · Cited by 917
Kawano, K., Hirashima, T., Mori, S., Saitoh, Y., Kurosumi, M., & Natori, T. (1992) · Diabetes · doi:10.2337/diabetes.41.11.1422 · Cited by 873
Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter.
Furth, P. A., St Onge, L., Böger, H., Gruss, P., Gossen, M., Kistner, A., Bujard, H., & Hennighausen, L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9302 · Cited by 770
Genetic Decreases in Atrial Natriuretic Peptide and Salt-Sensitive Hypertension
John, S. W. M., Krege, J. H., Oliver, P. M., Hagaman, J. R., Hodgin, J. B., Pang, S. C., Flynn, T. G., & Smithies, O. (1995) · Science · doi:10.1126/science.7839143 · Cited by 645
Lopez, M. J., Wong, S. K.-F., Kishimoto, I., Dubois, S., Mach, V., Friesen, J., Garbers, D. L., & Beuve, A. (1995) · Nature · doi:10.1038/378065a0 · Cited by 483
Cited by
Bioavailability of angiotensin I converting enzyme inhibitory peptides
Vermeirssen, V., Camp, J. V., & Verstraete, W. (2004) · British Journal of Nutrition · doi:10.1079/bjn20041189 · Cited by 548
Alterations in the gut microbiota can elicit hypertension in rats
Adnan, S., Nelson, J. W., Ajami, N. J., Venna, V. R., Petrosino, J. F., Bryan, R. M., & Durgan, D. J. (2017) · Physiological Genomics · doi:10.1152/physiolgenomics.00081.2016 · Cited by 383
Animal Models of Hypertension: A Scientific Statement From the American Heart Association
Lerman, L. O., Kurtz, T. W., Touyz, R. M., Ellison, D. H., Chade, A. R., Crowley, S. D., Mattson, D. L., Mullins, J. J., Osborn, J., Eirin, A., et al. (2019) · Hypertension · doi:10.1161/hyp.0000000000000090 · Cited by 329
Knowles, J. W., Esposito, G., Mao, L., Hagaman, J. R., Fox, J. E., Smithies, O., Rockman, H. A., & Maeda, N. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11273 · Cited by 302
Animal models in cardiovascular research: hypertension and atherosclerosis
Leong, X.-F., Ng, C.-Y., & Jaarin, K. (2015) · BioMed Research International · doi:10.1155/2015/528757 · Cited by 203
Metadata
- Authors
- Pinto, Y.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-07-01
- Volume
- 39
- Issue
- 1
- Pages
- 77-88
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W2336490398
- Cited by
- 340
- References
- 59
- FWCI
- 3.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lessons from rat models of hypertension from Goldblatt to genetic engineering. https://app.cochat.ai/papers/10.1016/s0008-6363(98)00077-7
- The paper
- Pinto, Y. (1998). Lessons from rat models of hypertension from Goldblatt to genetic engineering. Cardiovascular Research. https://doi.org/10.1016/s0008-6363(98)00077-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.